EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 70 filers reported holding EVOFEM BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $93,000 | -10.6% | 274,967 | -1.0% | 0.00% | – |
Q4 2021 | $104,000 | -49.3% | 277,834 | 0.0% | 0.00% | – |
Q3 2021 | $205,000 | -38.4% | 277,834 | -5.7% | 0.00% | – |
Q2 2021 | $333,000 | -77.0% | 294,720 | -64.3% | 0.00% | – |
Q1 2021 | $1,445,000 | -29.8% | 825,234 | -3.4% | 0.00% | – |
Q4 2020 | $2,058,000 | -0.2% | 853,869 | -2.3% | 0.00% | – |
Q3 2020 | $2,063,000 | +35.1% | 874,359 | +62.2% | 0.00% | – |
Q2 2020 | $1,527,000 | +58.7% | 539,193 | +198.2% | 0.00% | – |
Q1 2020 | $962,000 | -2.9% | 180,831 | +12.6% | 0.00% | – |
Q4 2019 | $991,000 | +4.3% | 160,562 | -14.8% | 0.00% | – |
Q3 2019 | $950,000 | +96.7% | 188,476 | +159.2% | 0.00% | – |
Q2 2019 | $483,000 | +302.5% | 72,709 | +112.4% | 0.00% | – |
Q1 2019 | $120,000 | – | 34,237 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,100,000 | $812,000 | 0.27% |
Westside Investment Management, Inc. | 10,000 | $7,230,000 | 0.02% |
Baker Brothers Advisors | 2,697,110 | $1,992,000 | 0.01% |
Bedel Financial Consulting, Inc. | 22,500 | $17,000 | 0.01% |
Congress Park Capital LLC | 14,500 | $11,000 | 0.01% |
Callan Capital, LLC | 50,000 | $37,000 | 0.01% |
FULLER & THALER ASSET MANAGEMENT, INC. | 1,079,860 | $798,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 60,381 | $45,000 | 0.01% |
Platform Technology Partners | 13,000 | $10,000 | 0.01% |
JB CAPITAL PARTNERS LP | 23,184 | $17,000 | 0.00% |